| Summary of Restricted Stock Activity |
Restricted stock activity for the year ended December 31, 2025 and the nine months ended September 30, 2026 was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RSA |
|
Weighted Average
Grant Price |
|
PRSU |
|
Weighted Average
Grant Price |
|
RSU |
|
Weighted Average
Grant Price |
|
Total |
|
Weighted Average
Grant Price |
Nonvested balance as of December 31, 2024 |
|
28,896 |
|
$30.09 |
|
49,630 |
|
$42.24 |
|
80,161 |
|
$36.04 |
|
158,687 |
|
$36.77 |
Granted (1) |
|
— |
|
— |
|
12,195 |
|
63.61 |
|
45,789 |
|
51.39 |
|
57,984 |
|
53.92 |
Vested |
|
(20,280) |
|
28.74 |
|
(15,825) |
|
42.70 |
|
(32,376) |
|
37.56 |
|
(68,481) |
|
37.21 |
Forfeited |
|
(976) |
|
33.60 |
|
— |
|
— |
|
(2,468) |
|
41.48 |
|
(3,444) |
|
40.79 |
Nonvested balance as of December 31, 2025 |
|
7,640 |
|
33.76 |
|
46,000 |
|
47.31 |
|
91,106 |
|
43.03 |
|
144,746 |
|
43.87 |
Granted (1) |
|
— |
|
— |
|
9,575 |
|
63.60 |
|
48,999 |
|
57.43 |
|
58,574 |
|
58.43 |
Vested |
|
(7,437) |
|
33.62 |
|
(16,780) |
|
40.26 |
|
(38,751) |
|
42.96 |
|
(62,968) |
|
40.96 |
Forfeited |
|
— |
|
— |
|
— |
|
— |
|
(9,008) |
|
46.70 |
|
(9,008) |
|
46.70 |
Nonvested balance as of September 30, 2026 |
|
203 |
|
$38.91 |
|
38,795 |
|
$54.38 |
|
92,346 |
|
$50.43 |
|
131,344 |
|
$51.58 |
Unrecognized compensation cost (in thousands) |
|
$1 |
|
|
|
$924 |
|
|
|
$3,577 |
|
|
|
$4,502 |
|
|
Weighted average remaining recognition period (in years) |
|
0.13 |
|
|
|
1.80 |
|
|
|
2.18 |
|
|
|
2.16 |
|
|
(1)The number of restricted shares/units shown includes the shares that would be granted if the target level of performance is achieved related to the PRSU. The number of shares actually issued may vary.
|
| Share-based Payment Arrangement, Expensed and Capitalized, Amount |
Share-based compensation expense related to restricted stock and ESPP included in the unaudited Consolidated Statements of Income was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended September 30, |
|
|
For the Nine Months Ended September 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
|
|
(In Thousands) |
|
Share-based compensation expense |
|
$ |
707 |
|
|
$ |
585 |
|
|
$ |
2,266 |
|
|
$ |
2,161 |
|
|